33 Participants Needed

Aliviado DSD Program for Dementia Caregivers

Recruiting at 1 trial location
YK
SL
Overseen ByShih-Yin Lin
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I have to stop taking my current medications to join the trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Aliviado DSD Program for Dementia Caregivers is an effective treatment?

The available research shows that similar programs to the Aliviado DSD Program, like the University of California, Los Angeles Alzheimer's and Dementia Care program, have led to improvements in caregiver depression, strain, and distress related to behavioral symptoms. Although not all participants showed improvement, most caregivers found the program very beneficial due to the support and access to dementia care experts. This suggests that the Aliviado DSD Program could also be effective in providing valuable support and improving the well-being of caregivers.12345

What safety data exists for the Aliviado DSD Program for Dementia Caregivers?

The provided research does not directly mention safety data for the Aliviado DSD Program or its other names. The studies focus on caregiver support programs, their implementation, and benefits, but do not specifically address safety data for the Aliviado DSD Program.678910

Is the Aliviado DSD Caregiving Mastery Program a promising treatment for dementia caregivers?

Yes, the Aliviado DSD Caregiving Mastery Program is a promising treatment for dementia caregivers. It aims to improve caregivers' skills and confidence, helping them manage the challenges of caring for someone with dementia more effectively.89101112

What is the purpose of this trial?

Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will develop a family-centered, mHealth-enhanced DSD caregiving mastery program ("Aliviado DSD Caregiving Mastery Program") through a 5-week co-design workshop with 8 family caregivers (Aim 1). The investigators will adapt/refine the existing clinician-centered DSD contents and an mHealth app from the evidence-based "Aliviado Dementia Care" program for use by family caregivers to support their day-to-day implementation of DSD detection, prevention, and management tasks in the community. Second, the investigators will pilot test the full Aliviado DSD Caregiving Mastery Program with 30 family caregivers of PLWD at high risk for delirium, assessing feasibility, acceptability, app usability, and preliminary program impact (Aim 2).

Research Team

SL

Shih-Yin Lin

Principal Investigator

NYU Rory Meyers College of Nursing

Eligibility Criteria

This trial is for English-speaking adults who provide at least 8 hours of unpaid care weekly or live with someone with dementia at high risk for delirium. They must be unfamiliar with DSD, able to consent, and have internet access via smartphone. Blind or deaf individuals cannot participate.

Inclusion Criteria

I am over 18, speak English, care for someone with dementia without pay, don't know much about DSD, can consent, and have Internet.

Exclusion Criteria

I am not blind or deaf.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Co-design Workshop

Development of the Aliviado DSD Caregiving Mastery Program through a 5-week co-design workshop with family caregivers

5 weeks

Caregiver Education/Training

Caregiver education and training period to learn about DSD prevention, detection, and management

2 weeks
Virtual sessions

Implementation

Implementation of the Aliviado DSD Caregiving Mastery Program by family caregivers

4 weeks
Weekly virtual check-ins

Follow-up

Participants are monitored for program impact, feasibility, and acceptability

4 weeks

Treatment Details

Interventions

  • Aliviado DSD Caregiving Mastery Program
Trial Overview The study tests the 'Aliviado DSD Caregiving Mastery Program,' designed to help family caregivers manage Delirium superimposed on Dementia (DSD) through a mobile health app and educational content over a 5-week workshop.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Family Caregivers of PLWD at High Risk for DeliriumExperimental Treatment1 Intervention
Participants will complete the Aliviado DSD Caregiving Mastery Program. This involves a caregiver education/training period from Week 0 to Week 2, and an implementation period from Week 3 to Week 6.

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The dementia Carer Education Programme increased carers' knowledge about dementia but did not significantly improve their quality of life, burden, or well-being after six months, based on a study of 32 carers.
Carers who reported a worsening situation post-programme experienced poorer quality of life and increased burden, highlighting that patient behavior disturbance was a key factor affecting their experience.
Dementia carer education and patient behaviour disturbance.Coen, RF., O'Boyle, CA., Coakley, D., et al.[2006]
The UCLA Alzheimer's and Dementia Care program showed overall improvements in behavioral and depressive symptoms for persons living with dementia and their caregivers after one year, despite disease progression.
A mixed-methods study identified seven areas for improvement in the program, highlighting that while some caregivers felt they did not benefit clinically, 85% still found the program very or extremely beneficial due to the supportive relationship with dementia care experts.
Caregiver outcomes of a dementia care program.Evertson, LC., Jennings, LA., Reuben, DB., et al.[2022]
The one-year activity-based day care program for dementia patients showed high attendance rates (91%) and strong enthusiasm from both patients and caregivers, indicating a positive reception of the program.
Despite the high engagement, patients did not report any improvement in their quality of life, and caregivers noted an increase in behavioral disturbances among patients, suggesting that while the program was well-received, it may not have effectively addressed the patients' needs.
Impact of an activities-based adult dementia care program.Higgins, M., Koch, K., Hynan, LS., et al.[2022]

References

Dementia carer education and patient behaviour disturbance. [2006]
Caregiver outcomes of a dementia care program. [2022]
Impact of an activities-based adult dementia care program. [2022]
Patient and Caregiver Outcomes and Experiences With Team-Based Memory Care: A Mixed Methods Study. [2021]
Systematic review of dyadic psychoeducational programs for persons with dementia and their family caregivers. [2023]
Memory Care and Wellness Services: Efficacy of Specialized Dementia Care in Adult Day Services. [2022]
Embedding caregiver support in community-based services for older adults: A multi-site randomized trial to test the Adult Day Service Plus Program (ADS Plus). [2023]
Building on Self-efficacy for Experienced Family Caregivers: The Savvy Advanced Program. [2020]
An Evaluation of Dementia Dialogues®: A Program for Informal and Formal Caregivers in North and South Carolina. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
The Savvy Caregiver program: the demonstrated effectiveness of a transportable dementia caregiver psychoeducation program. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Enhancing Dementia Knowledge and Self-Efficacy of In-Home Supportive Services Caregivers Through Online Training. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
The savvy caregiver program: developing and testing a transportable dementia family caregiver training program. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security